BackLeap Therapeutics Overview

Leap Therapeutics Net Income

Profitability analysis for LPTX.

Quarterly Net Income

-$77.17M
399.94% YoY

As of Mar 2026

Annual Net Income (TTM)

-$56.91M
17.73% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...